Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04119011Phase 2Completed
Phase 2, randomised, double-blind trial (2 arms), sponsored by Universiti Kebangsaan Malaysia. Primary endpoints: Pain Score (Visual Analog Scale) at 3 months, Severity Score (Verbal Rating Score) at 3 months and 2 more. Started Oct 2019; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04119011.